ArticleBMC molecular and cell biology2026
The Wnt/β-catenin pathway maintains homeostasis of amniocytes in Down syndrome.
Article in BMC molecular and cell biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundDown syndrome (DS), which is caused by partial or complete triplication of chromosome 21, may cause a range of clinical features. Although most fetuses with DS exhibit typical characteristics, the molecular pathogenesis underlying DS remains unclear. Wnt signaling is known to play a crucial role in fetal growth and development. However, the link between Wnt signaling and the abnormal development of fetuses with DS remains poorly understood. In this study, our objective was to investigate the dysregulation of the Wnt/β-catenin pathway in the amniocytes of fetuses diagnosed with DS. To this end, we obtained amniocytes from 10 fetuses diagnosed with DS and determined the expression levels of key proteins activated by the Wnt/β-catenin pathway, oxidative stress, cell proliferation, and apoptosis in these amniocytes using western blot and cellular immunofluorescence methods. Subsequently, components of the Wnt/β-catenin pathway were upregulated in amniocytes from fetuses diagnosed with DS and expression of related proteins was detected. The differences were evaluated using Student’s t-test or analysis of variance, followed by Tukey’s test.
resultsWe found that the Wnt/β-catenin pathway was inhibited in DS fetal amniocytes compared to normal fetal amniocytes, and cell proliferation was reduced, along with increased oxidative stress and apoptosis. In contrast, up-regulation of the Wnt/β-catenin pathway in DS amniocytes increased cell proliferation, decreased oxidative stress and apoptosis, and ultimately improved cell growth.
conclusionsThe Wnt/β-catenin pathway mitigates excessive apoptosis caused by oxidative stress, promotes cellular proliferation, and maintains homeostasis in DS amniocytes. These findings reveal a novel molecular mechanism underlying the abnormal regulation of the Wnt/β-catenin pathway during the development of fetuses with DS, thereby suggesting potential targeted therapies for DS.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.